Four lupane-type triterpenoids (1–4) and seven alkaloids (5–11) were isolated from the roots of Peganum nigellastrum. On the basis of spectroscopic and chemical evidence, the structures of the compounds were elucidated as 3α-hydroxy-27-trans-caffeoyloxylup-20(29)-en-28-oic acid methyl ester (1), 3β-hydroxy-27-trans-caffeoyloxylup-20(29)-en-28-oic acid methyl ester (2), 3α-acetoxy-27-trans-caffeoyloxylup-20(29)-en-28-oic acid methyl ester (3), 3β-acetoxy-27-trans-caffeoyloxylup-20(29)-en-28-oic acid methyl ester (4), luotonin C (5), luotonin D (6), harmine (7), harmol (8), harmaline (9), deoxyvasicinone (10) and vasicinone (11). Compounds 1, 3 and 4 are novel triterpenoids, and these pentacyclic triterpenoids were evaluated for their cytotoxicity against the androgen-sensitive LNCaP and androgen-independent PC-3 human prostate cancer cells.
FanZR, YaoXS. (1992) Compositions and pharmacological action of Peganum plants. Shenyang Yaoxueyuan Xuebao, 9, 144–151.
2.
DuanJA, ZhouRH, ZhaoSX, WangMS, CheCT. (1998) Studies on the chemical constituents of Peganum multisectum Maxim. I. The alkaloids from seeds and antitumor activity. Zhongguo Yaoke Daxue Xuebao, 29, 21–23.
3.
WangXW, XieH. (1999) Antineoplastic alkaloids from Peganum harmala. Drugs of the Future, 24, 1333–1337.
4.
LamchouriF, SettafA, CherrahY, HassarM, ZemzamiM, AtifN, NadoriEB, ZaidA, LyoussiB. (2000) In vitro cell-toxicity of Peganum harmala alkaloids on cancerous cell-lines. Fitoterapia, 71, 50–54.
5.
XieJC, ZhuLL, XuXJ. (2002) Affinitive separation and on-line identification of antitumor components from Peganum nigellastrum by coupling a chromatographic column of target analogue imprinted polymer with mass spectrometry. Analytical Chemistry, 74, 2352–2360.
6.
SobhaniAM, EbrahimiSA, MahmoudianM. (2002) An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its β-carboline alkaloids. Journal of Pharmacy & Pharmaceutical Sciences, 5, 18–22.
7.
XiaoPG. (1993) A Pictorial Encyclopedia of Chinese Medical Herbs. Chuokoron-sha, Tokyo, Japan, 3, 125.
8.
XiaoXH, QiuGL, WangHL, LiuLS, ZhengYL, JiaZJ, DengZB. (1988) Effect of alkaloids from Paganum nigellastum on mouse ascitic hepatoma and isolated cells. Zhongguo Yaolixue Yu Dulixue Zazhi, 2, 232–234.
9.
MaZZ, HanoY, NomuraT, ChenYJ. (1997) Two new pyrroloquinazolinoquinoline alkaloids from Peganum nigellastrum. Heterocycles, 46, 541–546.
10.
MaZZ, HanoY, NomuraT, ChenYJ. (2004) Novel quinazoline–quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities. Bioorganic & Medicinal Chemistry Letters, 14, 1193–1196.
11.
CagirA, JonesSH, GaoR, EisenhauerBM, HechtSM. (2003) Luotonin A. A naturally occurring human DNA topoisomerase I poison. Journal of the American Chemical Society, 125, 13628–13629.
12.
MaZZ, HanoY, NomuraT, ChenYJ. (2000) Three new triterpenoids from Peganum nigellastrum. Journal of Natural Products, 63, 390–392.
13.
XueHZ, LuZZ, KonnoC, SeojartoDD, CordellGA, FongHHS, HodgsonW. (1988) 3β-(3,4-Dihydroxycinnamoyl)-erythrodiol and 3β-(4-hydroxycinnamoyl)-erythrodiol from Larrea tridentate. Phytochemistry, 27, 233–235.
14.
SakurawiK, YasudaF, TozyoT, NakamuraM, SatoT, KikuchiJ, TeruiY, IkenishiY, IwataT, TakahashiK, KonoikeT, MiharaS, FujimotoM. (1996) Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivatives. Chemical & Pharmaceutical Bulletin, 44, 343–351.
15.
TchivoundaHP, KoudogboB, BesaceY, CasadevallE. (1990) Cylicodiscic acid, a dihydroxy pentacyclic triterpene carboxylic acid from Cylicodiscus gabunensis. Phytochemitry, 29, 3255–3258.
16.
Rudiyansyah, GarsonMJ. (2006) Secondary metabolites from the wood bark of Durio zibethinus and Durio kutejensis. Journal of Natural Products, 69, 1218–1221.
17.
MaZZ, HanoY, NomuraT, ChenYJ. (2000) Alkaloids and phenylpropanoids from Peganum nigellastrum. Phytochemistry, 53, 1075–1078.
WadaS, TanakaR. (2005) Betulinic acid and its derivatives, potent DNA topoisomerase II inhibitors, from the bark of Bischofia javanica. Chemistry & Biodiversity, 2, 689–694.
ZhouJR, YuL, ZerbiniLF, LibermannTA, BlackburnGL. (2004) Progression to androgen-independent LNCaP human prostate tumors: Cellular and molecular alterations. International Journal of Cancer, 110, 800–806.
22.
JiangRW, ZhouJR, HonPM, LiSL, ZhouY, LiLL, YeWC, XuHX, ShawPC, ButPPH. (2007) Lignans from Dysosma versipellis with inhibitory effects on prostate cancer cell lines. Journal of Natural Products, 70, 283–286.
